GUMENYUK, SVITLANA
 Distribuzione geografica
Continente #
NA - Nord America 1.818
EU - Europa 118
AS - Asia 76
SA - Sud America 3
Continente sconosciuto - Info sul continente non disponibili 1
Totale 2.016
Nazione #
US - Stati Uniti d'America 1.817
CN - Cina 51
IT - Italia 36
IE - Irlanda 22
DE - Germania 19
UA - Ucraina 14
SG - Singapore 9
FR - Francia 6
GB - Regno Unito 6
KR - Corea 6
RU - Federazione Russa 5
FI - Finlandia 4
HK - Hong Kong 4
IN - India 3
BR - Brasile 2
HR - Croazia 2
MY - Malesia 2
BE - Belgio 1
CA - Canada 1
CH - Svizzera 1
CL - Cile 1
CZ - Repubblica Ceca 1
EU - Europa 1
JP - Giappone 1
PL - Polonia 1
Totale 2.016
Città #
Wilmington 528
Houston 464
Woodbridge 424
Chandler 79
Fairfield 67
Ashburn 35
Seattle 33
Cambridge 25
Dublin 22
Dearborn 21
Beijing 19
Rome 19
Medford 16
New York 16
Ann Arbor 12
Singapore 9
Hangzhou 8
Lawrence 8
Munich 7
Guangzhou 6
Jacksonville 5
Moscow 5
Bari 4
Brindisi 4
Hackensack 4
San Diego 4
Shanghai 4
Boardman 3
Palo Alto 3
Wellesley 3
Center 2
Central 2
Changsha 2
Creede 2
Hefei 2
Hong Kong 2
Kuala Lumpur 2
Kunming 2
London 2
Nuremberg 2
Rosignano Marittimo 2
São Paulo 2
Zagreb 2
Augusta 1
Brno 1
Chongqing 1
Colorado Springs 1
Corona 1
Council Bluffs 1
Falls Church 1
Fuzhou 1
Hebei 1
Jinhua 1
Lappeenranta 1
Latina 1
Meulebeke 1
Milan 1
Monte Vista 1
Mountain View 1
Mumbai 1
Mülheim 1
Nanchang 1
Nanjing 1
Norwalk 1
Paris 1
Prescot 1
Pune 1
Redmond 1
Redwood City 1
Sarno 1
Secaucus 1
Seoul 1
Taizhou 1
Tokyo 1
Toronto 1
Zhengzhou 1
Totale 1.916
Nome #
Cryotherapy reduces oral mucositis and febrile episodes in myeloma patients treated with high-dose melphalan and autologous stem cell transplant: a prospective, randomized study 400
Real-life use of erythropoiesis-stimulating agents in myelodysplastic syndromes: a "Gruppo Romano Mielodisplasie (GROM)" multicenter study 382
Ponatinib Induces a Persistent Molecular Response and Graft-versus-Host Disease/Graft-versus-Leukemia Effect in a Patient with Philadelphia-Positive Acute Lymphoblastic Leukemia with a T315I Mutation following Early Relapse after Allogeneic Transplant 371
A Population-Based Study on Myelodysplastic Syndromes in the Lazio Region (Italy), Medical Miscoding and 11-Year Mortality Follow-Up: the Gruppo Romano-Laziale Mielodisplasie Experience of Retrospective Multicentric Registry 365
BEAM vs FEAM high-dose chemotherapy: retrospective study in lymphoma patients undergoing autologous stem cell transplant 136
Prospective surveillance vs clinically driven approach for CMV reactivation after autologous stem cell transplant 127
Comparison between biosimilar filgrastim vs other granulocyte-colony stimulating factor formulations (originator filgrastim, peg-filgrastim and lenograstim) after autologous stem cell transplantation: a retrospective survey from the Rome Transplant Network 108
Association between CMV and invasive fungal infections after autologous stem cell transplant in lymphoproliferative malignancies: Opportunistic partnership or cause-effect relationship? 93
Myelodysplastic syndromes with del(5q): A real-life study of determinants of long-term outcomes and response to lenalidomide 48
Daratumumab combined with dexamethasone and lenalidomide or bortezomib in relapsed/refractory multiple myeloma (RRMM) patients: Report from the multiple myeloma GIMEMA Lazio group 28
Totale 2.058
Categoria #
all - tutte 4.876
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 4.876


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020571 35 35 32 39 42 53 48 40 74 73 55 45
2020/2021421 51 49 58 45 55 44 43 40 8 16 9 3
2021/202268 5 9 2 1 0 7 6 1 5 4 6 22
2022/2023174 13 18 4 30 19 30 22 6 16 8 2 6
2023/2024101 9 4 4 7 9 21 2 8 8 3 2 24
2024/20253 3 0 0 0 0 0 0 0 0 0 0 0
Totale 2.058